Two administrators at Research Triangle Charter Academy, Melanie Stack and Nicole Scotto, pleaded guilty to obstruction of ...

Elon Musk discusses the convergence of AI, robotics, energy, and space tech as critical to humanity's future. There are bottlenecks in power, chips, and ...

One way leads to a future in which AI-driven breakthroughs remain the exclusive domain of pharmaceutical giants with billion-dollar budgets. The other, to a landscape where breakthroughs regularly ...

Python.Org is the official source for documentation and beginner guides. Codecademy and Coursera offer interactive courses for learning Python basics. Think Python provides a free e-book for a ...

This forms a "recursive feedback loop," whereby AI models design the next generation of chips and those chips, in turn, train ...

We asked certified financial planners, investment advisers and other money experts their thoughts on stock choices this year ...

Ricursive Intelligence, a frontier AI lab founded by the co-creators of AlphaChip, today announced a $300 million Series A funding round led by Lightspeed Venture Partners at a $4 billion post-money ...

Ricursive Intelligence, a frontier AI lab, announced on Monday that it has raised $300 million in a Series A round of funding ...

ChatGPT’s newest model has been caught leaning on Grokipedia, an AI-written encyclopedia created by Elon Musk’s xAI, to answer some of the internet’s most obscure questions. Instead of drawing only on ...

'Mad Money' host Jim Cramer weighs in on stocks including: Recursion Pharmaceuticals and NuScale Power. Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more ...

This is this week’s ForbesWomen newsletter, which every Thursday brings news about the world’s top female entrepreneurs, leaders and investors straight to your inbox. Click here to get on the ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...